SparingVision

About:

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

Website: https://sparingvision.com

Twitter/X: SparingVision

Top Investors: Bpifrance, Intellia Therapeutics, Foundation Fighting Blindness, UPMC Enterprises, Ysios Capital

Description:

SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent treatment for retinitis pigmentosa, the most common inherited retinal degeneration. There is currently no treatment to treat all genetic forms of this rare retinal disease that leads to blindness and affects nearly 2 million people worldwide.